Screening of Dengue Virus Antiviral Activity of Marine Seaweeds by an In Situ Enzyme-Linked Immunosorbent Assay

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Koishi, Andrea Cristine ^a,b   Zanello, Paula Rodrigues ^b   Bianco, Éverson Miguel ^c,d   Bordignon, Juliano ^b   Nunes Duarte dos Santos, Claudia ^b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b INSTITUTO CARLOS CHAGAS   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALGAL EXTRACT; CANISTROCARPUS CERVICORNIS EXTRACT; CAULERPA RACEMOSA EXTRACT; PADINA GYMNOSPORA EXTRACT; PALISADA PERFORATE EXTRACT; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; BROWN ALGA; CELL VIABILITY; CHEMICAL STRUCTURE; DENGUE; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GREEN ALGA; HUMAN; HUMAN CELL; IMMUNODETECTION; INTERNALIZATION; NONHUMAN; RED ALGA; RELIABILITY; SEAWEED; SEROTYPE; VALIDATION STUDY; VIRUS INFECTION; VIRUS STRAIN;

ANTIVIRAL AGENTS; CELL DEATH; CELL LINE, TUMOR; DENGUE; DENGUE VIRUS; DRUG EVALUATION, PRECLINICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; REPRODUCIBILITY OF RESULTS; SEAWATER; SEAWEED; VIRUS INTERNALIZATION;

CAULERPA RACEMOSA; CHLOROPHYTA; DENGUE VIRUS; PADINA GYMNOSPORA; PHAEOPHYCEAE; RHODOPHYTA;

EID: 84870798620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051089     Document Type: Article

References (51)

1. World Health Organization (2009) Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. France: WHO Press. 147 p.
2. Guha-Sapir D, Schimmer B, (2005) Dengue fever: new paradigms for a changing epidemiology. Emerg Themes Epidemiol 2: 1.
3. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH, (2011) Economic impact of dengue illness in the Americas. Am J Trop Med Hyg 84: 200-207.
4. Henchal EA, Putnak JR, (1990) The dengue viruses. Clin Microbiol Rev 3: 376-396.
5. Chambers TJ, Hahn CS, Galler R, Rice CM, (1990) Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44: 649-688.
6. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8: S7-S16.
7. Malavige GN, Fernando S, Fernando DJ, Seneviratne SL, (2004) Dengue viral infections. Postgrad Med J 80: 588-601.
8. Halstead B, O'Rourke EJ, (1977) Dengue viruses and mononuclear phagocytes I. Infection enhancement by non-neutralizing antibody. J Exp Med 146: 201-217.
9. Nielsen DG, (2009) The relationship of interacting immunological components in dengue pathogenesis. J Virol 6: 211.
10. Rothman AL, Ennis FA, (1999) Immunopathogenesis of dengue hemorrhagic fever. Virology 6: 1-6.
11. BIO Ventures for Global Health (2007) Dengue Fever. Available: http://www.bvgh.org/Biopharmaceutical-Solutions/Global-Health-Primer/Diseases/cid/ViewDetails/ItemID/3.aspx. Accessed 2012 Nov 2.
12. Wang Q-Y, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, et al. (2009) A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother 53: 1823-1831.
13. Lescar J, Luo D, Xu T, Sampath A, Lim SP, et al. (2008) Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res 80: 94-101.
14. Zhang XG, Mason PW, Dubovi EJ, Xu X, Bourne N, et al. (2009) Antiviral activity of geneticin against dengue virus. Antiviral Res 83: 21-27.
15. Sayce AC, Miller JL, Zitzmann N, (2010) Targeting a host process as an antiviral approach against dengue virus. Trends Microbiol 18: 323-330.
16. Yin Z, Chen Y-L, Schul W, Wang Q-Y, Gu F, et al. (2009) An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A 106: 20435-20439.
17. Yasuhara-Bell J, Lu Y, (2010) Marine compounds and their antiviral activities. Antiviral Res 86: 231-240.
18. Che P, Wang L, Li Q, (2009) The development, optimization and validation of an assay for high throughput antiviral drug screening against Dengue virus. Int J Clin Exp Med 2: 363-373.
19. Shum D, Smith JL, Hirsch AJ, Bhinder B, Radu C, et al. (2010) High-content assay to identify inhibitors of dengue virus infection. Assay Drug Dev Technol 8: 553-570.
20. Qing M, Liu W, Yuan Z, Gu F, Shi PY, (2010) A high-throughput assay using dengue-1 virus-like particles for drug discovery. Antiviral Res 86: 163-171.
21. Myc A, Anderson MJ Jr JRB, (1999) Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents. J Virol Methods 77: 165-177.
22. Berkowitz FE, Levin MJ, (1985) Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against Varicella-Zoster Virus. Antimicrob Agents Chemother 28: 207-210.
23. Ljungdahlstahle E, Schloss L, Sundqvist V, Brytting M, Hokeberg I, et al. (1998) Solid phase ELISA for determination of the virus dose dependant sensitivity of human cytomegalovirus to antiviral drugs in vitro. Antiviral Res 40: 105-112.
24. Desprès P, Frenkiel MP, Deubel V, (1993) Differences between cell membrane fusion activities of two dengue type-1 isolates reflect modifications of viral structure. Virology 196: 209-219.
25. Oliveira AS de, Cavalcanti DN, Bianco EM, Paula JC de, Pereira RC, et al. (2008) Chemical composition of diterpenes from the brown alga Canistrocarpus cervicornis (Dictyotaceae, Phaeophyceae). Nat Prod Commun 3: 1469-1472.
26. Chiba K, Kawakami K, Tohyama K, (1998) Simultaneous evaluation of cell viability by neutral red, MTT and crystal violet staining assays of the same cells. Toxicol in vitro 12: 251-258.
27. Talarico LB, Pujol CA, Zibetti RGM, Faría PCS, Noseda MD, et al. (2005) The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Res 66: 103-110.
28. De Burghgraeve T, Kaptein SJF, Ayala-Nunez NV, Mondotte JA, Pastorino B, et al. (2012) An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro. PloS one 7: e37244.
29. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV, (1992) Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30: 545-551.
30. Zhang J-H, (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4: 67-73.
31. Figueiredo LT, Shope RE, (1987) An enzyme immunoassay for dengue antibody using infected cultured mosquito cells as antigen. J Virol Methods 17: 191-198.
32. Figueiredo LTM, Simões MC, Cavalcante SMB, (1989) Enzyme immunoassay for the detection of dengue IgG and IgM antibodies using infected mosquito cells as antigen. Trans R Soc Trop Med Hyg 83: 702-707.
33. Chen Y-L, Yin Z, Duraiswamy J, Schul W, Lim CC, et al. (2010) Inhibition of dengue virus RNA synthesis by an adenosine nucleoside. Antimicrob Agents Chemother 54: 2932-2939.
34. Chen Y-L, Yin Z, Lakshminarayana SB, Qing M, Schul W, et al. (2010) Inhibition of dengue virus by an ester prodrug of an adenosine analog. Antimicrob Agents Chemother 54: 3255-3261.
35. Jamur MC, Oliver C (2010) Cell Fixatives for Immunostaining. In: Jamur MC, Oliver C, editors. Immunocytochemical Methods and Protocols. Humana Press. 55-61.
36. Clercq ED (2009) Antiviral drug discovery: ten more compounds, and ten more stories (Part B). Med Res Rev 29.
37. Crance JM, Scaramozzino N, Jouan A, Garin D, (2003) Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res 58: 73-79.
38. Kim EJ, Park SY, Lee J, Han J, Park Y, (2010) Fucoidan present in brown algae induces apoptosis of human colon cancer cells. BMC Gastroenterol 10: 96.
39. Khanavi M, Nabavi M, Sadati N, Shams Ardekani M, Sohrabipour J, et al. (2010) Cytotoxic activity of some marine brown algae against cancer cell lines. Biol Res 43: 31-37.
40. Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
41. Repetto G, del Peso A, Zurita JL, (2008) Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 3: 1125-1131.
42. Borenfreund E, Babich H, Martin-Alguacil N, (1988) Comparisons of two in vitro cytotoxicity assays-The neutral red (NR) and tetrazolium MTT tests. Toxicol in Vitro 2: 1-6.
43. Hong J, (2011) Role of natural product diversity in chemical biology. Curr Opin Chem Biol 15: 350-354.
44. Mora C, Tittensor DP, Adl S, Simpson AGB, Worm B, (2011) How many species are there on earth and in the ocean? PLoS Biol 9: e1001127.
45. Stengel DB, Connan S, Popper ZA, (2011) Algal chemodiversity and bioactivity: Sources of natural variability and implications for commercial application. Biotechnol Adv 29: 483-501.
46. Hidari KIPJ, Takahashi N, Arihara M, Nagaoka M, Morita K, et al. (2008) Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem Biophys Res Commun 376: 91-95.
47. Harden EA, Falshaw R, Carnachan SM, Kern ER, Prichard MN, (2009) Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus. Antiviral Res 83: 282-289.
48. Ferreira LDS, Turatti ICC, Lopes NP, Guaratini T, Colepicolo P, et al. (2012) Apolar compounds in seaweeds from Fernando de Noronha archipelago (northeastern coast of Brazil). Int J Anal Chem 2012: 431954.
49. Marques CT, Azevedo TCGD, Benevides NMB, Rocha HAO, Lisboa E, (2012) Sulfated fucans extracted from algae Padina gymnospora have anti-inflammatory effect. Rev bras farmacogn 22: 115-122.
50. Fujii MT, Cassano V, Stein ÉM, Carvalho LR, (2011) Overview of the taxonomy and of the major secondary metabolites and their biological activities related to human health of the Laurencia complex (Ceramiales, Rhodophyta) from Brazil. Rev bras farmacogn 21: 268-282.
51. Aliya R, Shameel M, (2003) Marine natural products of Caulerpa (Siphonocladophyceae). Pak J Bot 35: 659-669.